Ifp Advisors, Inc Karuna Therapeutics, Inc. Transaction History
Ifp Advisors, Inc
- $2.05 Billion
- Q4 2023
A detailed history of Ifp Advisors, Inc transactions in Karuna Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 820 shares of KRTX stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
820
Previous 830
1.2%
Holding current value
$0
Previous $140,000
85.0%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding KRTX
# of Institutions
13Shares Held
333KCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V8213KShares$00.06% of portfolio
-
Tekla Capital Management LLC58.6KShares$00.5% of portfolio
-
International Biotechnology Trust PLC London, X030.5KShares$01.75% of portfolio
-
Ea Series Trust Havertown, PA12.8KShares$00.1% of portfolio
-
Brinker Capital Investments, LLC6.1KShares$00.02% of portfolio
About Karuna Therapeutics, Inc.
- Ticker KRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,965,000
- Description
- Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...